DK258280A - Fremgangsmaade til fremstilling af oxymorfon - Google Patents

Fremgangsmaade til fremstilling af oxymorfon

Info

Publication number
DK258280A
DK258280A DK258280A DK258280A DK258280A DK 258280 A DK258280 A DK 258280A DK 258280 A DK258280 A DK 258280A DK 258280 A DK258280 A DK 258280A DK 258280 A DK258280 A DK 258280A
Authority
DK
Denmark
Prior art keywords
oxymorphone
procedure
manufacturing
Prior art date
Application number
DK258280A
Other languages
Danish (da)
English (en)
Inventor
M L Wilson
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Publication of DK258280A publication Critical patent/DK258280A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08Oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polarising Elements (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK258280A 1978-10-19 1980-06-17 Fremgangsmaade til fremstilling af oxymorfon DK258280A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95305678A 1978-10-19 1978-10-19
PCT/US1979/000862 WO1980000841A1 (fr) 1978-10-19 1979-10-18 Procede de preparation de l'oxymorphone

Publications (1)

Publication Number Publication Date
DK258280A true DK258280A (da) 1980-06-17

Family

ID=25493512

Family Applications (1)

Application Number Title Priority Date Filing Date
DK258280A DK258280A (da) 1978-10-19 1980-06-17 Fremgangsmaade til fremstilling af oxymorfon

Country Status (16)

Country Link
JP (1) JPS55501025A (fr)
AU (1) AU5189779A (fr)
BE (1) BE879494A (fr)
CA (1) CA1108132A (fr)
CS (1) CS211364B2 (fr)
DK (1) DK258280A (fr)
ES (1) ES485154A1 (fr)
FI (1) FI793235A (fr)
FR (1) FR2439201A1 (fr)
GB (1) GB2049680A (fr)
IL (1) IL58489A0 (fr)
IT (1) IT7969032A0 (fr)
NL (1) NL7920126A (fr)
NO (1) NO793297L (fr)
SE (1) SE8004454L (fr)
WO (1) WO1980000841A1 (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795813A (en) * 1981-08-17 1989-01-03 The Florida Board Of Regents On Behalf Of The Florida State University Synthesis of derivatives of codeine and other 3-O-alkylmorphines
US5668285A (en) * 1986-10-31 1997-09-16 The United States Of America As Represented By The Department Of Health And Human Services Total synthesis of northebaine, normophine, noroxymorphone enantiomers and derivatives via N-Nor intermediates
FR2636330B1 (fr) * 1988-09-13 1990-11-30 Sanofi Sa Procede de preparation de derives de morphinane
ES2129395T3 (es) * 1989-10-16 1999-06-16 Us Health Sintesis total de enantiomeros de nortebaina, normorfina, noroximorfona y sus derivados a traves de productos intermedios n-nor.
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
EP1414458B1 (fr) 2001-07-06 2007-04-11 Endo Pharmaceuticals Inc. Administration orale de 6-hydroxy-oxymorphone utilise en tant qu'analgesique
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
JP5695296B2 (ja) 2006-03-02 2015-04-01 マリンクロッド エルエルシー 低レベルのアルファ,ベータ−不飽和ケトン化合物を伴うモルフィナン−6−オン生成物の製造方法
JP5774853B2 (ja) 2008-01-25 2015-09-09 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 医薬投薬形
TWI524904B (zh) 2008-05-09 2016-03-11 歌林達股份有限公司 製備醫藥用固體劑型,尤指錠劑之方法,及製備固體劑型,尤指錠劑之前驅物之方法
JP2012533586A (ja) 2009-07-22 2012-12-27 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 酸化安定化された不正使用防止剤形
CA2765971C (fr) 2009-07-22 2017-08-22 Gruenenthal Gmbh Forme galenique extrudee a chaud a liberation controlee
NZ608865A (en) 2010-09-02 2015-03-27 Gruenenthal Chemie Tamper resistant dosage form comprising an anionic polymer
AU2011297901B2 (en) 2010-09-02 2014-07-31 Grunenthal Gmbh Tamper resistant dosage form comprising inorganic salt
PT2736497T (pt) 2011-07-29 2017-11-30 Gruenenthal Gmbh Comprimido resistente a adulteração proporcionando libertação imediata de fármaco
CN103841964A (zh) 2011-07-29 2014-06-04 格吕伦塔尔有限公司 提供药物立即释放的抗破碎片剂
JP6117249B2 (ja) 2012-02-28 2017-04-19 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 薬理学的に活性な化合物および陰イオン性ポリマーを含むタンパーレジスタント剤形
WO2013156453A1 (fr) 2012-04-18 2013-10-24 Grünenthal GmbH Forme pharmaceutique inviolable et résistante à la libération massive
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
MX371432B (es) 2013-05-29 2020-01-30 Gruenenthal Gmbh Forma de dosificacion resistente al uso indebido que contiene una o mas particulas.
CA2913209A1 (fr) 2013-05-29 2014-12-04 Grunenthal Gmbh Forme dosifiee inviolable a profil de liberation bimodale
MX368846B (es) 2013-07-12 2019-10-18 Gruenenthal Gmbh Forma de dosificación resistente a la alteración que contiene polímero de acetato de etilen-vinilo.
EP3073994A1 (fr) 2013-11-26 2016-10-05 Grünenthal GmbH Préparation de composition pharmaceutique en poudre par cryo-broyage
EP3142646A1 (fr) 2014-05-12 2017-03-22 Grünenthal GmbH Formulation pour capsule à libération immédiate résistant aux manipulations illicites comprenant du tapentadol
EA201692388A1 (ru) 2014-05-26 2017-05-31 Грюненталь Гмбх Лекарственная форма в виде множества частиц, защищенная от вызываемого этанолом сброса дозы
EA035434B1 (ru) 2015-04-24 2020-06-15 Грюненталь Гмбх Защищенная от применения не по назначению лекарственная форма с немедленным высвобождением и устойчивостью к экстракции растворителями
EP3346991A1 (fr) 2015-09-10 2018-07-18 Grünenthal GmbH Protection contre un surdosage par voie orale à l'aide de formulations à libération immédiate dissuasives d'abus
ES2701855T3 (es) 2016-05-31 2019-02-26 Alcaliber Investig Desarrollo E Innovacion Slu Proceso para la obtención de 3,14-diacetiloximorfona a partir de oripavina

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3249616A (en) * 1966-05-03 Ix-dfflydroxy-g-oxo-n-phenethylmor- phinan (cis) and production thereof
US2806033A (en) * 1955-08-03 1957-09-10 Lewenstein Morphine derivative
US3775414A (en) * 1972-05-10 1973-11-27 Bristol Myers Co Process for the preparation of 14-hydroxymorphinan derivatives

Also Published As

Publication number Publication date
FR2439201A1 (fr) 1980-05-16
AU5189779A (en) 1980-04-24
FI793235A (fi) 1980-04-20
WO1980000841A1 (fr) 1980-05-01
GB2049680A (en) 1980-12-31
IT7969032A0 (it) 1979-10-18
CA1108132A (fr) 1981-09-01
JPS55501025A (fr) 1980-11-27
NO793297L (no) 1980-04-22
CS211364B2 (en) 1982-02-26
BE879494A (fr) 1980-02-15
SE8004454L (sv) 1980-06-16
ES485154A1 (es) 1980-06-16
NL7920126A (nl) 1980-08-29
IL58489A0 (en) 1980-01-31

Similar Documents

Publication Publication Date Title
DK258280A (da) Fremgangsmaade til fremstilling af oxymorfon
DK325079A (da) Fremgangsmaade til fremstilling af tiazolidinderivater
DK365079A (da) Fremgangsmaade til fremstilling af 1-alfa-hydroxylerede calciferoler
DK156779A (da) Fremgangsmaade til fremstilling af cycloalkyltriazoler
DK129879A (da) Fremgangsmaade til fremstilling af n-heterocyclyl-4-piperidinaminer
DK37879A (da) Fremgangsmaade til fremstilling af oligoimider
DK68179A (da) Fremgangsmaade til fremstilling af 9-aminodibenzoepyraner
DK268579A (da) Fremgangsmaade til fremstilling af phenetamolaminer
DK77479A (da) Fremgangsmaade til fremstilling af penicilliner
DK380579A (da) Fremgangsmaade til fremstilling af formlegemer af ekspanderet formstof
DK307279A (da) Fremgangsmaade til fremstilling af phenolethere
DK480679A (da) Fremgangsmaade til fremstilling af cephalosporinforbindelser
DK150984C (da) Fremgangsmaade til kontinuerlig fremstilling af azopigmenter
DK148259C (da) Fremgangsmaade til fremstilling af lysergolderivater
DK265779A (da) Fremgangsmaade til fremstilling af o-methallyloxyphenol
DK69479A (da) Fremgangsmaade til fremstilling af 2-phenylimino-imidazolidiner
DK452679A (da) Fremgangsmaade til fremstilling af cephalosporinforbindelser
DK433779A (da) Fremgangsmaade til fremstilling af phenylquinolizidiner
DK150471C (da) Fremgangsmaade til fremstilling af trifluormethylphenoler
DK543079A (da) Fremgangsmaade til fremstilling af benzaldehyder
DK58579A (da) Fremgangsmaade til fremstilling af hydroxyphenylethere
DK424279A (da) Fremgangsmaade til fremstilling af formlegemer
DK145179A (da) Fremgangsmaade til fremstilling af 4-methyl-5-hydroxymethyl-imidazol
DK77179A (da) Fremgangsmaade til fremstilling af androstadiener
DK92192A (da) Fremgangsmaade til fremstilling af a-homo-androstaner